Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells

Fengqin Dong, Wei Guo, Lidong Zhang, Shuhong Wu, Fuminori Teranishi, John J. Davis, Bingliang Fang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Small-molecule inhibitors of cyclin-dependent kinases (CDKs) are known to induce cell cycle arrest and apoptosis in certain cancer cells. In order to evaluate the antitumor activity of one such inhibitor, GW8510, against human lung cancers, we analyzed the effects of GW8510 on six nonsmall cell lung cancer (NSCLC) cell lines (A549, H1299, H460, H226, H358 and H322) and normal human fibroblast (NHFB). We treated the cells with GW8510 at concentrations of 0-10 μM, and found that it suppressed cell growth in vitro in all the lung cancer cells but not in NHFB. Subsequent study showed that GW8510 induced apoptosis and cell cycle arrest in the A549, H1299 and H460 cells in a time-and dose-dependent manner. Western blot analysis showed that GW8510 downregulated the expression of X-linked inhibitor of apoptosis (XIAP) but had no detectable effect on the expression of Bax, Bak, or Bcl2. GW8510 also downregulated XIAP mRNA level, suggesting that downregulation of XIAP expression occurs at the transcriptional level. Moreover, ectopic XIAP expression diminished growth inhibition and apoptosis induction by GW8510. Importantly, GW8510 was not capable of inducing apoptosis of NHFB cells. These results suggest that GW8510 might provide a treatment strategy for human NSCLC and XIAP is an important target for GW8510-induced apoptosis of NSCLC cells that occurs through inhibition of XIAP mRNA transcription.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalCancer Biology and Therapy
Volume5
Issue number2
DOIs
Publication statusPublished - Jan 1 2006
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinases
Non-Small Cell Lung Carcinoma
Down-Regulation
Apoptosis
Fibroblasts
Cell Cycle Checkpoints
Lung Neoplasms
GW8510
Messenger RNA
Growth
Western Blotting

Keywords

  • Apoptosis
  • Cyclin-dependent kinases
  • Non-small lung cancer
  • Small molecule
  • X-linked inhibitor of apoptosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells. / Dong, Fengqin; Guo, Wei; Zhang, Lidong; Wu, Shuhong; Teranishi, Fuminori; Davis, John J.; Fang, Bingliang.

In: Cancer Biology and Therapy, Vol. 5, No. 2, 01.01.2006, p. 165-170.

Research output: Contribution to journalArticle

Dong, Fengqin ; Guo, Wei ; Zhang, Lidong ; Wu, Shuhong ; Teranishi, Fuminori ; Davis, John J. ; Fang, Bingliang. / Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells. In: Cancer Biology and Therapy. 2006 ; Vol. 5, No. 2. pp. 165-170.
@article{c328237752b64c93a7dc006e670660f4,
title = "Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells",
abstract = "Small-molecule inhibitors of cyclin-dependent kinases (CDKs) are known to induce cell cycle arrest and apoptosis in certain cancer cells. In order to evaluate the antitumor activity of one such inhibitor, GW8510, against human lung cancers, we analyzed the effects of GW8510 on six nonsmall cell lung cancer (NSCLC) cell lines (A549, H1299, H460, H226, H358 and H322) and normal human fibroblast (NHFB). We treated the cells with GW8510 at concentrations of 0-10 μM, and found that it suppressed cell growth in vitro in all the lung cancer cells but not in NHFB. Subsequent study showed that GW8510 induced apoptosis and cell cycle arrest in the A549, H1299 and H460 cells in a time-and dose-dependent manner. Western blot analysis showed that GW8510 downregulated the expression of X-linked inhibitor of apoptosis (XIAP) but had no detectable effect on the expression of Bax, Bak, or Bcl2. GW8510 also downregulated XIAP mRNA level, suggesting that downregulation of XIAP expression occurs at the transcriptional level. Moreover, ectopic XIAP expression diminished growth inhibition and apoptosis induction by GW8510. Importantly, GW8510 was not capable of inducing apoptosis of NHFB cells. These results suggest that GW8510 might provide a treatment strategy for human NSCLC and XIAP is an important target for GW8510-induced apoptosis of NSCLC cells that occurs through inhibition of XIAP mRNA transcription.",
keywords = "Apoptosis, Cyclin-dependent kinases, Non-small lung cancer, Small molecule, X-linked inhibitor of apoptosis",
author = "Fengqin Dong and Wei Guo and Lidong Zhang and Shuhong Wu and Fuminori Teranishi and Davis, {John J.} and Bingliang Fang",
year = "2006",
month = "1",
day = "1",
doi = "10.4161/cbt.5.2.2316",
language = "English",
volume = "5",
pages = "165--170",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "2",

}

TY - JOUR

T1 - Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells

AU - Dong, Fengqin

AU - Guo, Wei

AU - Zhang, Lidong

AU - Wu, Shuhong

AU - Teranishi, Fuminori

AU - Davis, John J.

AU - Fang, Bingliang

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Small-molecule inhibitors of cyclin-dependent kinases (CDKs) are known to induce cell cycle arrest and apoptosis in certain cancer cells. In order to evaluate the antitumor activity of one such inhibitor, GW8510, against human lung cancers, we analyzed the effects of GW8510 on six nonsmall cell lung cancer (NSCLC) cell lines (A549, H1299, H460, H226, H358 and H322) and normal human fibroblast (NHFB). We treated the cells with GW8510 at concentrations of 0-10 μM, and found that it suppressed cell growth in vitro in all the lung cancer cells but not in NHFB. Subsequent study showed that GW8510 induced apoptosis and cell cycle arrest in the A549, H1299 and H460 cells in a time-and dose-dependent manner. Western blot analysis showed that GW8510 downregulated the expression of X-linked inhibitor of apoptosis (XIAP) but had no detectable effect on the expression of Bax, Bak, or Bcl2. GW8510 also downregulated XIAP mRNA level, suggesting that downregulation of XIAP expression occurs at the transcriptional level. Moreover, ectopic XIAP expression diminished growth inhibition and apoptosis induction by GW8510. Importantly, GW8510 was not capable of inducing apoptosis of NHFB cells. These results suggest that GW8510 might provide a treatment strategy for human NSCLC and XIAP is an important target for GW8510-induced apoptosis of NSCLC cells that occurs through inhibition of XIAP mRNA transcription.

AB - Small-molecule inhibitors of cyclin-dependent kinases (CDKs) are known to induce cell cycle arrest and apoptosis in certain cancer cells. In order to evaluate the antitumor activity of one such inhibitor, GW8510, against human lung cancers, we analyzed the effects of GW8510 on six nonsmall cell lung cancer (NSCLC) cell lines (A549, H1299, H460, H226, H358 and H322) and normal human fibroblast (NHFB). We treated the cells with GW8510 at concentrations of 0-10 μM, and found that it suppressed cell growth in vitro in all the lung cancer cells but not in NHFB. Subsequent study showed that GW8510 induced apoptosis and cell cycle arrest in the A549, H1299 and H460 cells in a time-and dose-dependent manner. Western blot analysis showed that GW8510 downregulated the expression of X-linked inhibitor of apoptosis (XIAP) but had no detectable effect on the expression of Bax, Bak, or Bcl2. GW8510 also downregulated XIAP mRNA level, suggesting that downregulation of XIAP expression occurs at the transcriptional level. Moreover, ectopic XIAP expression diminished growth inhibition and apoptosis induction by GW8510. Importantly, GW8510 was not capable of inducing apoptosis of NHFB cells. These results suggest that GW8510 might provide a treatment strategy for human NSCLC and XIAP is an important target for GW8510-induced apoptosis of NSCLC cells that occurs through inhibition of XIAP mRNA transcription.

KW - Apoptosis

KW - Cyclin-dependent kinases

KW - Non-small lung cancer

KW - Small molecule

KW - X-linked inhibitor of apoptosis

UR - http://www.scopus.com/inward/record.url?scp=33644657066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644657066&partnerID=8YFLogxK

U2 - 10.4161/cbt.5.2.2316

DO - 10.4161/cbt.5.2.2316

M3 - Article

VL - 5

SP - 165

EP - 170

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 2

ER -